CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk› Healthcare› Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd

BSE 524731 JENBURPH INE354A01013
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

10 filings · 2 material · busiest 2026-08-03 and 2026-08-06

What it files

Newspaper Publication2 Board Outcome1 Results1 Annual Report1 AGM / EGM1 Board Meeting1 Registered Office1 Compliance Certificate1

Filings

10 in the window

  1. 7 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication for standalone Unaudited Financial Results for the quarter ended on 30th June, 2026.

    Company Update / Newspaper Publication View filing →

  2. 6 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 06Th August, 2026.

    Outcome of the Board Meeting held today on 06th August, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  3. 6 August 2026

    Results

    Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2026.

    Standalone Unaudited Financial Results for the quarter ended on 30th June, 2026.

    Result / Financial Results View filing →

  4. 4 August 2026

    Newspaper Publication

    Newspaper Publication

    Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are enclosing herewith clippings of the Newspaper publication for Notice of the 41st AGM of the Company.

    Company Update / Newspaper Publication View filing →

  5. 3 August 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Submission of the Annual Report for the FY 2025-26, containing Audited Standalone Financial Statements, Auditors Report and Directors Report and the Notice convening 41st Annual General ....

    Others / Reg. 34 (1) Annual Report View filing →

  6. 3 August 2026

    AGM / EGM

    Notice Of The 41St Annual General Meeting Of The Company Schedule To Be Held On Friday, 04Th September, 2026 Through VC/OAVM.

    Notice of the 41st Annual General Meeting of the Company Schedule to be held on Friday, 04th September, 2026, through VC/OAVM.

    AGM/EGM / AGM View filing →

  7. 29 July 2026

    Board Meeting

    Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2026.

    Jenburkt Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve standalone unaudited ....

    Board Meeting / Board Meeting View filing →

  8. 13 July 2026

    Registered Office

    Change in Registered Office Address

    Intimation of shifting of Registered Office of the Company within the local limits of city of Mumbai.

    Company Update / Change in Registered Office Address View filing →

  9. 10 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended on 30th June, 2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  10. 18 June 2026

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window of Jenburkt Pharmaceuticals Limited as per SEBI(Prohibition of Insider Trading) Regulations, 2015.

    Insider Trading / SAST / Closure of Trading Window View filing →